Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Textor

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Transplantation Proceedings|February 1, 1993
Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipientsM K Porayko, S C Textor, R A Krom, et al.
Mayo Clinic Proceedings|February 1, 1994
Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantationM K Porayko, S C Textor, R A Krom, et al.
Mayo Clinic Proceedings|December 1, 1994
Cyclosporine-induced hypertension after transplantationS C Textor, V J Canzanello, S J Taler, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 9, 2010
The outcome of patients with nephrogenic systemic fibrosis after successful kidney transplantationN Leung, A Shaikh, F G Cosio, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 14, 2006
Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimusT S Larson, P G Dean, M D Stegall, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 14, 2006
Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN)H M Wadei, A D Rule, M Lewin, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Transplantation Proceedings|February 1, 1993
Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipientsM K Porayko, S C Textor, R A Krom, et al.
Mayo Clinic Proceedings|February 1, 1994
Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantationM K Porayko, S C Textor, R A Krom, et al.
Mayo Clinic Proceedings|December 1, 1994
Cyclosporine-induced hypertension after transplantationS C Textor, V J Canzanello, S J Taler, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 9, 2010
The outcome of patients with nephrogenic systemic fibrosis after successful kidney transplantationN Leung, A Shaikh, F G Cosio, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 14, 2006
Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimusT S Larson, P G Dean, M D Stegall, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 14, 2006
Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN)H M Wadei, A D Rule, M Lewin, et al.
Pageof 9